On November 21, 2024, the FDA’s Center for Devices and Radiological Health (CDRH) announced a pilot to minimize the time between the FDA’s initial awareness of a potentially high-risk medical device removal or correction and the agency’s public communication of what was potentially a high risk recall, the most serious kind of recall. While the FDA may not have determined that a company’s actions had met the regulatory definition of a recall, the “Early Alert” communications included information on when companies removed products from the market, corrected products, or updated instructions for using products due to potentially high safety risks. Known as the Early Alert Pilot, it was developed as part of CDRH’s ongoing efforts to enhance the recall program as outlined in the 2024 Safety Report, and following recommendations from the Patient Engagement Advisory Committee (PEAC) meeting held Oct. 6, 2021. The program was designed using feedback from patients, health care providers, and consumers to make recall communications more timely, clear, and action-oriented.

After the success of the pilot, Early Alert communications expanded on Sept. 29, 2025, and CDRH will now issue Early Alerts for potentially high-risk removals or corrections for all medical devices.

Publication of Early Alerts is another example of CDRH’s commitment to providing clear and timely notifications to patients, consumers, and health care providers about the safety and effectiveness of medical devices. The FDA will keep the public informed and update our website as significant new information becomes available.

FDA Actions

Additional Resources

  • Content current as of:

    09/29/2025

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.